These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20147322)

  • 1. Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria.
    Lavigne JP; Brunel JM; Chevalier J; Pagès JM
    J Antimicrob Chemother; 2010 Apr; 65(4):799-801. PubMed ID: 20147322
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the antibacterial mechanism of action of squalamine.
    Alhanout K; Malesinki S; Vidal N; Peyrot V; Rolain JM; Brunel JM
    J Antimicrob Chemother; 2010 Aug; 65(8):1688-93. PubMed ID: 20551217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR
    J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
    [No Abstract]   [Full Text] [Related]  

  • 5. Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria.
    Iredell J; Thomas L; Power D; Mendes E
    J Antimicrob Chemother; 2007 Apr; 59(4):816-8. PubMed ID: 17353224
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitivity of multiresistant bacterial strains to imipenem (Tienam)].
    Ruczkowska J; Dolna I
    Przegl Lek; 1992; 49(5):151-3. PubMed ID: 1438917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].
    Grigore L
    Bacteriol Virusol Parazitol Epidemiol; 1996; 41(3-4):151-60. PubMed ID: 9116405
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gram-negative bacteria isolated from wound infections and their susceptibility to various antibiotics].
    Durupinar B; Ozkuyumcu C; Dikmen N
    Mikrobiyol Bul; 1989 Jul; 23(3):238-45. PubMed ID: 2487464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Acute bacterial prostatitis in Korea.
    Etienne M; Caron F
    Int J Antimicrob Agents; 2009 Aug; 34(2):185-6. PubMed ID: 19342203
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance of Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Arya SC; Agarwal N
    Saudi Med J; 2004 Sep; 25(9):1305. PubMed ID: 15448801
    [No Abstract]   [Full Text] [Related]  

  • 12. Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
    Toltzis P
    Minerva Pediatr; 2003 Oct; 55(5):385-93. PubMed ID: 14608262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum beta-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience.
    Zaki Mel S
    J Infect Dev Ctries; 2007 Dec; 1(3):269-74. PubMed ID: 19734604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
    Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
    Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
    Shibl AM; Ishag AH; Durgham SM
    J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
    Akinci E; Colpan A; Bodur H; Balaban N; Erbay A
    J Hosp Infect; 2005 Apr; 59(4):317-23. PubMed ID: 15749320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and anti-microbial susceptibility of gram-negative bacteria isolated from bloodstream infections of cancer patients on chemotherapy in Pakistan.
    Saghir S; Faiz M; Saleem M; Younus A; Aziz H
    Indian J Med Microbiol; 2009; 27(4):341-7. PubMed ID: 19736404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High activity of meropenem against Gram-negative bacteria from a paediatric Intensive Care Unit, 2001-2005.
    Patzer JA; Dzierzanowska D; Pawińska A; Turner PJ
    Int J Antimicrob Agents; 2007 Mar; 29(3):285-8. PubMed ID: 17257814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.